UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dynamics of drug resistance-associated mutations in HIV-1 DNA reverse transcriptase sequence during effective ART

Journal of antimicrobial chemotherapy, 2018-08, Vol.73 (8), p.2141-2146

2018

Volltextzugriff (PDF)

Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination

Journal of antimicrobial chemotherapy, 2016-08, Vol.71 (8), p.2248-2251

2016

Volltextzugriff (PDF)

Performance of genotypic algorithms for predicting tropism for HIV-1 CRF01_AE recombinant

Journal of clinical virology, 2018-02, Vol.99-100, p.57-60

2018

Volltextzugriff (PDF)

Disparities in HIV‐1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations

HIV medicine, 2017-10, Vol.18 (9), p.696-700

2017

Volltextzugriff (PDF)

Genetic impact of raltegravir long-term antiretroviral therapy on herpes simplex virus Type 2

Journal of clinical virology, 2015-09, Vol.70, p.S16-S17

2015

Volltextzugriff (PDF)

Performance of genotypic algorithms for predicting tropism of HIV-1CRF02_AG subtype

Journal of clinical virology, 2016-03, Vol.76, p.51-54

2016

Volltextzugriff (PDF)

377 Propionibacterium acnes CAMP factor 1 recognized Toll-Like Receptor-2

Journal of investigative dermatology, 2017-10, Vol.137 (10), p.S257-S257

2017

Volltextzugriff (PDF)

Mitochondrial Dysfunction and β-Cell Failure in Type 2 Diabetes Mellitus

Experimental diabetes research, 2012-01, Vol.2012 (2012), p.1-11

2012

Volltextzugriff (PDF)

E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure

AIDS (London), 2012-08, Vol.26 (13), p.1619-1624

2012

Volltextzugriff (PDF)

Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretrovirals

AIDS (London), 2010-09, Vol.24 (15), p.2313-2321

2010

Volltextzugriff (PDF)

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

AIDS (London), 2011-01, Vol.25 (3), p.341-344

2011

Volltextzugriff (PDF)

Genetic impact of raltegravir long-term antiretroviral therapy on herpes simplex virus Type 2: Presentation at ESCV 2015: Oral 35

Journal of clinical virology, 2015-09, Vol.70, p.S16-S17

2015

Volltextzugriff (PDF)

Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination

Journal of antimicrobial chemotherapy, 2016-07, Vol.71 (8), p.2248-2251

2016

Volltextzugriff (PDF)

Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes

Journal of antimicrobial chemotherapy, 2015-01, Vol.70 (1), p.130-135

2015

Volltextzugriff (PDF)

Frequency of amino acid changes associated with resistance to attachment inhibitor BMS-626529 in R5- and X4-tropic HIV-1 subtype B

Journal of antimicrobial chemotherapy, 2013-06, Vol.68 (6), p.1243-1245

2013

Volltextzugriff (PDF)

The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype

Journal of antimicrobial chemotherapy, 2011-12, Vol.66 (12), p.2827-2830

2011

Volltextzugriff (PDF)

Resistant minority species are rarely observed in patients on darunavir/ritonavir monotherapy

Journal of antimicrobial chemotherapy, 2012-06, Vol.67 (6), p.1470-1474

2012

Volltextzugriff (PDF)

Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients

Journal of antimicrobial chemotherapy, 2011-07, Vol.66 (7), p.1481-1483

2011

Volltextzugriff (PDF)

Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies

Journal of antimicrobial chemotherapy, 2013-12, Vol.68 (12), p.2882-2889

2013

Volltextzugriff (PDF)

Risk factors for raltegravir resistance development in clinical practice

Journal of antimicrobial chemotherapy, 2012-10, Vol.67 (10), p.2494-2500

2012

Volltextzugriff (PDF)

Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes

Antiviral therapy, 2014-01, Vol.19, p.A114-A114

2014

Volltextzugriff (PDF)

Highly multi-drug resistant HIV: clonal analysis and therapeutic strategies

Antiviral therapy, 2013-01, Vol.18, p.A101-A101

2013

Volltextzugriff (PDF)

Low frequency of amino acid changes associated with resistance to attachment inhibitor BMS-626529 in R5- and X4-tropic HIV-1 B subtypes

Antiviral therapy, 2013-01, Vol.18, p.A32-A32

2013

Volltextzugriff (PDF)

The Relationship between Spending Behavior and Student Financial Management Skills

International Multidisciplinary Research Journal, 2023-06, Vol.5 (1)

2023

Volltextzugriff (PDF)

1 – 25 von 454

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(376)
Mit Volltextzugriff
(385)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Dynamics of drug resistance-associated mutations in HIV-1 DNA reverse transcriptase sequence during effective ART

Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination

Performance of genotypic algorithms for predicting tropism for HIV-1 CRF01_AE recombinant

Disparities in HIV‐1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations

Genetic impact of raltegravir long-term antiretroviral therapy on herpes simplex virus Type 2

Performance of genotypic algorithms for predicting tropism of HIV-1CRF02_AG subtype

377 Propionibacterium acnes CAMP factor 1 recognized Toll-Like Receptor-2

Mitochondrial Dysfunction and β-Cell Failure in Type 2 Diabetes Mellitus

E138K and M184I mutations in HIV-1 reverse transcriptase coemerge as a result of APOBEC3 editing in the absence of drug exposure

Partially active HIV-1 Vif alleles facilitate viral escape from specific antiretrovirals

Higher efficacy of nevirapine than efavirenz to achieve HIV-1 plasma viral load below 1 copy/ml

Genetic impact of raltegravir long-term antiretroviral therapy on herpes simplex virus Type 2: Presentation at ESCV 2015: Oral 35

Usefulness of an HIV DNA resistance genotypic test in patients who are candidates for a switch to the rilpivirine/emtricitabine/tenofovir disoproxil fumarate combination

Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes

Frequency of amino acid changes associated with resistance to attachment inhibitor BMS-626529 in R5- and X4-tropic HIV-1 subtype B

The HIV-1 integrase G118R mutation confers raltegravir resistance to the CRF02_AG HIV-1 subtype

Resistant minority species are rarely observed in patients on darunavir/ritonavir monotherapy

Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients

Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies

Risk factors for raltegravir resistance development in clinical practice

Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes

Highly multi-drug resistant HIV: clonal analysis and therapeutic strategies

Low frequency of amino acid changes associated with resistance to attachment inhibitor BMS-626529 in R5- and X4-tropic HIV-1 B subtypes

The Relationship between Spending Behavior and Student Financial Management Skills

Independent Role of Severe Obesity as a Risk Factor for COVID‐19 Hospitalization: A Spanish Population‐Based Cohort Study

Suchergebnisse filtern